DJIA: 18,080.14  +21.45 (0.12%) | NASDAQ: 5,092.085  +36.021 (0.71%) | S&P 500: 2,117.69  +4.76 (0.23%) Markets closed

  • Show Article Details

    Shares of 3D Systems (DDD) are down by 4.68% to $28.74 in mid-morning trading on Friday, after the company issued its preliminary 2015 first quarter earnings results which fell short of what analysts are expecting the 3D printing company to report for the period.

  • Show Article Details

    Xerox (XRX) shares are down 9.4% to $11.91 in early market trading on Friday after the document technology service provider reported its first quarter financial results before the opening bell today.The Norwalk, CT-based company reported first quarter net income of $225 million, or 21 cents per diluted share when adjusted for one time losses, on revenue of $4.47 billion that fell 6.3% from the same p...

  • Show Article Details

     Biogen shares are falling 5.88% to $405 in early market trading on Friday after the global biopharmaceutical company reported its first quarter earnings results before the opening bell today.The Cambridge, MA-based company reported first quarter earnings of $3.82 per share on revenue that rose 20% to $2.55 billion.

  • Show Article Details

    German industrial group ThyssenKrupp plans to invest more than 800 million euros in North America by 2020 to take advantage of the economy's reindustrialization. "We are profiting from economic growth and the renaissance of manufacturing in the USA.

  • Show Article Details

    - Xerox Corp (XRX), cut its 2015 profit forecast, blaming a strong dollar, and reported quarterly revenue below Wall Street's expectations, hurt mainly by lower printer sales and higher costs. The company also said it expects 2015 revenue to fall 1 percent on a constant currency basis, compared with its previous forecast of revenue being flat with a year earlier.

  • Show Article Details

    * Stock falls as much at 8 pct. * Tecfidera sales fall 10 pct on sequential basis in 1st qtr. * Co also experiencing strong currency headwinds - executives. By Natalie Grover. Sales of Biogen Inc's (BIIB) key oral multiple sclerosis drug Tecfidera fell on a sequential basis in the first quarter for the first time since its launch in 2013, sending the company's stock down as much as 8 percent on Friday.

  • Show Article Details

    Foreigners are set to take over several French blue chip firms this year and will largely do what they want with their prizes - showing the limits of new laws passed in the name of "economic patriotism".

  • Show Article Details

    * Sarao said he "always" traded very fast. * Complaint says Sarao canceled 99 pct of orders on certain days. * Sarao had nearly $17 mln in assets in Swiss bank -court document. By Sarah N. Lynch, Tom Polansek and Douwe Miedema.

  • Show Article Details

    - Microsoft Corp on Thursday reported revenue and profit above Wall Street expectations, as sales of its hardware and cloud-computing services helped to offset a decline in the company's core Windows business. Shares rose 3.1 percent to $44.70 in after-hours trading. "The company beat across the board," said FBR Capital markets analyst Daniel Ives.